Quoin Pharmaceuticals Ltd. Profit Loss
Quoin Pharmaceuticals Ltd. (QNRX) reported Profit Loss of ILS 9.85 million for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-24.
Discontinued › Income Statement › Net Income
ifrs-full:ProfitLoss · last filed 2021-08-24
ILS
| Period end | Profit Loss 6 month | Profit Loss 6 month as first filed | Profit Loss 12 month |
|---|---|---|---|
| 2021-06-30 | 9.85M ILS 6-K · filed 2021-08-24 | ||
| 2020-12-31 | -18.08M ILS 20-F · filed 2021-03-29 | ||
| 2020-06-30 | 11.36M ILS 6-K · filed 2021-08-24 | -11.36M ILS 6-K/A · filed 2021-02-11 | |
| 2019-12-31 | -16.81M ILS 20-F · filed 2021-03-29 | ||
| 2019-06-30 | -5.92M ILS 6-K/A · filed 2021-02-11 | ||
| 2018-12-31 | -20.11M ILS 20-F · filed 2021-03-29 | ||
| 2018-06-30 | -9.56M ILS 6-K · filed 2019-08-13 | ||
| 2017-12-31 | -28.22M ILS 20-F · filed 2020-04-03 | ||
| 2017-06-30 | -17.05M ILS 6-K · filed 2018-08-09 | ||
| 2016-12-31 | -15.32M ILS 20-F · filed 2019-03-18 | ||
| 2015-12-31 | -10.17M ILS 20-F · filed 2018-03-19 |
USD
| Period end | Profit Loss 6 month | Profit Loss 12 month |
|---|---|---|
| 2021-06-30 | $3.02M 6-K · filed 2021-08-24 | |
| 2020-12-31 | -$5.62M 20-F · filed 2021-03-29 | |
| 2019-12-31 | -$4.86M 20-F · filed 2020-04-03 | |
| 2018-06-30 | -$2.62M 6-K · filed 2018-08-09 | |
| 2017-12-31 | -$8.14M 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |